Track 1: Diabetes Surgery:
Diabetes is traditionally viewed as a chronic and relentless disease in which delay of end-organ complications is the major goal in treatment, bariatric surgery offers a novel endpoint: complete disease remission or major improvement.
Bariatric surgeries constitute a powerful option to ameliorate diabetes in patients affected by obesity severely. Bariatric surgery is an appropriate treatment for people with Type 2 Diabetes and obesity not achieving recommended treatment targets with other medical therapies and also very cost - effective.
Diabetes Surgery: A New Discipline
Diabetes and Bariatric Surgery
Diabetes and Metabolic surgeries
Diabetes and Sleeve gastrectomy
Diabetes and Heart / Vascular Surgery
Diabetes organ transplantation / organ removal surgery
The Risks and complications of Surgery for Diabetics
Diabetes Surgery: Opportunities, Barriers, and Limitations
Track 2: Advanced technologies for the treatment of diabetes:
The artificial pancreas bridges of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). A large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2 diabetes. Insulin administration is essential for the patients of type 2.
Present insulin delivery systems are available as transdermal injections. Several approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections.
Informatics in the service of medicine; telemedicine, software and other technologies
New insulin delivery systems: Inhaled, transdermal, and implanted devices
Blood glucose monitoring: Glucose pumps and sensors
Insulin pumps and insulin infusion systems
Insulin secretion in vitro and exocytosis
Insulin Pens and novel Insulin delivery techniques
Acupuncture for diabetic complications
Glucose sensors (invasive and non-invasive)
Closed-loop system and algorithm
Track 3: Diabetes medication:
Anti-Diabetic Medications work by two mechanisms either lowering blood glucose level or by increasing sensitivity to insulin. People can self-inject insulin under the skin if hospitalized a doctor/nurse might inject insulin directly into the blood.
There are several different types of insulin-like Rapid-acting injections that take less time to show effect i.e within 5 to 15 minutes but lasts for a shorter time period of 3 to 5 hours, Short-acting injections take 30 minutes and 1 hour time to show effect and last for 6 to 8 hours. Intermediate-acting injections that take about 1 to 4 hours to show effect and it last for 10 to 26 hours, Long-acting injections show effect after 1 or 2 hours and it last for between 14 and 24 hours.
Other than insulin there are many other oral antidiabetic medications which are non-insulin injectables in the market. They include Biguanides, Sulphonylureas, Meglitinides, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Gestational diabetes.
Neonatal diabetes
Pediatric diabetes
Factors considered in selecting proper medications
Bio availability and bio equivalence of drugs in diabetic patients
Track 4: Global Market for Diabetes and its Research:
Diabetic drugs have the highest market shares amongst drugs and devices compared to other and are also expected to have the highest rate in growth with a CAGR of 8.9%. Diabetic drugs are highly priced it would be one of the major drawbacks.
Diabetic devices include insulin delivery devices and blood glucose meters. The market for blood glucose meters is having the top market shares compared to the insulin delivery systems such as syringes and injection pens. Meter and strips are one of the most expected to dominate the overall market share in diabetic devices.
Global Demographics & Market Dynamics
Comprehensive research methodology of Diabetes market
Analysis of regional regulations
Insights about market determinants
Global Challenges and Unmet Needs
Comprehensive research methodology of Diabetes market
Track 5: Cancer, Gestational Diabetes and Obesity:
Additional fat in the body may have destructive impacts, such as producing hormones and development factors can influence the way our cells work. Fat cells can also attract immune cells to body tissues which release chemicals that cause a long-term inflammation. Individuals with obesity have chronic low-level or subacute unresolved inflammations, which is related to expanded malignancy chance.
Gestational diabetes cause problems for your baby and you during pregnancy and after birth. But the risks can be reduced if the condition is detected early and well managed.Gestational diabetes is high blood sugar (glucose) that develops during pregnancy. It happens when your body cannot produce enough insulin – a hormone that helps control blood sugar levels – to meet your extra needs in pregnancy.
Genetic Linkage
Medication for Diabetes and Cancer
Diagnosis
Case Studies
Obesity and Reproductive Function
Track 6: Biomarkers and Biosimilars in Diabetes:
Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product. Human bio monitoring (HBM) is a tool of health-related environmental monitoring.
Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes. Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.
Scope and Role of Biomarkers
Biomarker Application in diabetes research
Novel Biomarkers
Biosimilar Development, Review, and Approval
Biosimilar and Interchangeable Products
Prescribing Biosimilar and Interchangeable Products
Biosimilar Product Information
Track 7: Diabetes Mellitus:
Diabetes Mellitus is a chronic condition with abnormally high levels of sugar in the blood. Insulin is produced by the pancreas then it lowers blood glucose. During, Absence or insufficient production of insulin, or an inability of the body to properly use insulin causes diabetes.
Gastrointestinal motility disorders are common in patients with diabetes mellitus. It has been estimated that more than 75% of diabetics may have gastrointestinal symptoms directly related to the effects of diabetic neuropathy.
Diabetes causes vary depending on our genetic makeup, family history, ethnicity, health and environmental factors. Type 1 diabetes is an autoimmune condition which means that the immune system mistakenly attacks and destroys the beta cells in the pancreas that then produce insulin. Type 2 diabetes starts as insulin resistance. It means that the body cannot use insulin efficiently which stimulates your pancreas to produce more insulin. Gestational diabetes is also due to insulin-blocking hormones produced during pregnancy.
Gastrointestinal
Type 1 diabetes
Type 2 diabetes
Pre-diabetes
Gestational diabetes
Track 8: Emerging Technologies for Diabetes Care:
Diabetes is a serious issue which is still uncured and makes new research, in treatment and management techniques is a crucial necessity. Over the past years, there have been considerable breakthroughs in preventing diabetic complications by understanding them.
Nanotechnology in diabetes is the advancement of novel glucose estimation and insulin conveyance modalities that hold the possibility to drastically enhance the personal satisfaction for diabetics. Nano-medication is typically 10-100 times littler than a body's phone yet just minimal bigger than particles makes conceivable the treatment of the starting point of diabetes at the atomic level.
Nanotechnology in diabetes
Artificial organ transplantation technology
Human Recombinant Insulin
Digital Healthcare: Designing the Digital Solution
Blood Glucose Monitoring and Glycemic Control in the Hospitals
Computerised applications in Diabetes mitigations
Informatics in the Service of Medicine, Telehealth, Telemedicine, Software and other Technologies
Clinical Decision Support Systems/Advisors
Securing funding for diabetes technology
Track 9: Diabetes: Health Education & Health Promotion:
Health education is a combination of learning experiences designed to help individuals or communities improve their health, by increasing their knowledge or influencing their attitudes, by focusing on prevention. Diabetes education will reduce the costs that individuals, families, insurance companies, medical facilities, communities, the state, and the nation would spend on medical treatment.
Health promotion is the process of enabling people to increase control over and to improve their health, it moves beyond a focus on individual behavior towards the wide range of environmental and social interventions.
Public Awareness Campaigns
Promotional Initiatives – Webinars, Books & Publications
Track 10: Medical Devices used in Diabetes Treatment:
Most common medical devices used in diabetes diagnosis and treatment include blood-glucose meters, insulin pens, insulin pumps. These devices include glucose ministering devices, Bioartificial pancreas, insulin delivery systems, and insulin administrating systems. And many diabetes monitoring and diagnostic devices like lancets, analog glucose monitor, test Strips, Syringe, Injectors also come under this. And these devices are designed to be feasible to use and painless in the insertion. Some companies are joining up and put their efforts to create a contact lens that measures the glucose in tears.
Insulin Pens and novel Insulin delivery techniques
Tear glucose monitoring contact lenses
Continuous glucose monitoring (CGM)/ Blood Glucose Meters
The future: the Artificial Beta Cell
Artificial pancreas
New Insulin Analogues
Blood glucose monitoring: Glucose pumps & sensors
Intravenous blood glucose monitoring systems
Insulin dose calculation software
Flash Glucose Monitoring
Closed-loop system and algorithm
New insulin delivery systems: Inhaled, transdermal patches, and implanted devices
Track 11: Diabetes and its Complications:
Excess amounts of sugars or glucose in the blood lead to such a chronic condition called diabetes mellitus. High glucose in blood may cause eye damage, kidney damage, and nerve damage. Diabetes increases the risk of different cardiovascular diseases, such as coronary heart disease, heart attack, heart stroke and narrowing of arteries which diminishes the blood move through the arteries.
The abnormal rise of glucose in the blood can harm veins and nerves of the eye, which leads to loss of visions.Diabetes is the main cause of cardiovascular diseases, kidney diseases and loss of vision.
Diabetic cardiomyopathy
Diabetic Nephropathy
Diabetic Neuropathy
Diabetic Retinopathy
Diabetes Dermatology
Diabetes Pediatrics
Diabetes and Oral health
Diabetes and Colo-Rectal Cancer
Track 12: Diabetes Management:
Diabetes Management mainly aims to minimize the risk of long-term consequences associated with diabetes. It not only involves keeping a check on blood glucose, blood pressure, and cholesterol levels but also focussing on modern approaches like exercise, diet and lifestyle management often coupled with on-going blood glucose level monitoring. Self-management of diabetes is also another crucial thing for proper adherence to dietary and lifestyle modifications.
Regular check-ups on cholesterol, blood pressure, HDL, LDL & triglyceride levels, and eye examination to prevent diabetic retinopathy, foot care specialist is to prevent diabetes occurrence. And the other complications caused due to other diseases such are obesity, cancer are to be treated or prevented.
Diabetic Diet Management- Food, micronutrients
Clinical care management of Diabetes - Medication
Management of Neonatal and Pediatric diabetes
Management of Gestational Diabetes / Menstruation and menopause (Diabetic women)
Management of Diabetes hypertension / blood pressure
Management of Diabetic Cardiovascular Diseases
Management of Diabetic Eye Diseases
Management of Diabetic Kidney Diseases
Management of Diabetic Foot Diseases
Management of Neuro Diabetes
Management of Diabetes obesity
Track 13: Pediatric Endocrinology Vs Pediatric Cardiology:
Pediatric Endocrinology is a medicinal sub-specialty managing the development issue and sexual differentiation in children. Additionally, it is associated with neonatal diabetes and the different issue of the endocrine organs. Pediatric Endocrinology incorporates the investigation of type 1 and type 2 diabetes in the infants.
The Division of Pediatric Cardiology oversees the analysis of congenital heart defects, performing the diagnostic procedure such as echocardiograms, cardiac catheterizations, and electrophysiology. There are additionally other pericardial diseases that can introduce clinically as acute pericarditis, pericardial effusion, heart tamponade, and constrictive pericarditis.
Disease associated with Pediatric Endocrinology
Pediatric Cardiology
Disease associated with Pediatric Endocrinology Cardiology
Track 14: Diabetes Research and therapy:
Diabetes research takes many forms throughout the world. Diabetes research is a global task. In this review, we explore what an ideal diabetes therapy would look like from the perspective of several key in diabetes drug development. Increased diabetes was the leading cause of blindness, kidney failure, and non-traumatic lower-limb amputations.
Diabetes therapies are described by their brand names to differentiate new therapies with generic names similar to those of existing therapies and to draw distinctions between separate therapies that share the same generic names.
Anatomy of Endocrine system
Endocrine Tissues and Organs
Role of DNA methylation in insulin secretion
Intravenous blood glucose monitoring systems
Insulin dose calculation software
Flash Glucose Monitoring
Closed-loop system and algorithm
Track 15: Diabetic psychological care:
The importance of the psychological state consultants in the management of medically ill individuals has grown with the proliferation of information linking health and behavior.
People with diabetes experience disproportionately high rates of mental health issues such as anxiety, depression and eating disorders. Most of the studies state that people with diabetes must have access to psychological treatment and support in order to reduce psychological distress and improve self-management.
Diabetes Psychological care
Role of the Psychologist in Diabetes
Psychosocial Factors in Diabetes Care : emotional factors, social factors, behavioral factors
Psychopathology in Diabetes
Emotional and psychological needs for diabetic individuals.
Psychosocial Issues Unique to Children and Adolescents
Track 16: Pharmacoeconomics: Diabetes:
Pharmacoeconomic research is the process of identifying, measuring and comparing the costs, risks and benefit of services, therapies and determining which alternatives can produce the best health outcomes for resource invested. Diabetes mellitus patients require frequent monitoring of blood glucose levels, anti-diabetic drugs on a chronic basis and all of which result in a significant economic burden on the diabetes patients and the world economies.
Diabetes with complications results in double the cost when compared to diabetes alone, so that the burden of diabetes and its complications was significant for an individual. This cost associated with the disease is preventable by diet restriction and aerobic exercise, to reduce the prevalence of diabetes and its complications in mind.
Pharmacoeconomic challenges in the management of diabetes
Methods of Pharmacoeconomics
Humanistic Evaluation Methods
Pharmacoeconomic Controversy
Pharmacoeconomic Consequences
Drug Therapy Evaluation
Clinical Pharmacy Service Evaluation
Naturalistic pharmacoeconomic studies
Strategies to Incorporate Pharmacoeconomics into Pharmacotherapy
Track 17: Pharmacogenetics: Diabetes:
Genomic studies have greatly advanced our understanding of the multifactorial aetiology of diabetes especially in type 2 diabetes (Diabetes Mellitus) as well as the multiple subtypes of monogenic diabetes mellitus. These studies focus on a few feasible candidate genes involved in drug pharmacodynamics / pharmacokinetics, or those associated with Type 2 diabetes as a disease phenotype.Here in relation to diabetes the main focus is on mostly used drugs in diabetes treatment such as sulfonylureas, metformin and thiazolidinediones (troglitazone, pioglitazone, and rosiglitazone).
Genomics
Chemogenomics
Clinomics
Genetic engineering
Toxicogenomics
Metabolomics
Pharmacovigilance
Population groups in biomedicine
Toxgnostics
Medical terminology
Track 18: Eating Disorders:
Eating Disorder is basically portrayed by abnormal consumption of food which contrarily influences a man's psychological and physical health. This dysfunctional behavior has six broad types which incorporate binge eating disorder, anorexia nervosa, bulimia nervosa, rumination disorder, restrictive food intake disorder and other specified feeding or eating disorder.
This Psychiatric Disorder creates a bad impact on the body weight of a person. Anorexia nervosa is generally regular among young ladies with a risk group of 15-19-year-old young girls. Very nearly half of individuals with eating disorders meet the criteria for depression. Both hereditary and ecological factor plays a role in Eating Disorder. Treatment incorporates Counselling, appropriate eating diet, and medication.
Diagnostic Methods
Pathophysiology of Eating Disorder
Personality Traits
Compulsive Overeating
Case Studies and Risk Factor
Track 19: Metabolic Response and Nutrition:
Nutrition & Metabolism centers around the coordination of sustenance, practice physiology, clinical examinations, and atomic and cell natural chemistry of digestion. Metabolic impacts of dietary protein are unpredictable
The dietary prerequisites of a neonate are fundamentally more noteworthy than those of a grown-up in light of the fact that not exclusively are there necessities for substrate admission.
Response to ingested Glycine
Metabolic response to Hypoxia
Track 20: Diabetes induced Heart Complications:
Heart Diseases describes a range of conditions that influence your heart. Disease under the coronary illness umbrella incorporates blood vessel diseases. For example, coronary artery disease; heart rhythm problems (arrhythmias), congenital heart defects, Rheumatic heart disease, Hypertensive heart disease, Ischemic heart disease, Hypertension.
Heart failure is a condition in which your heart can't pump enough blood to address your body's issues. The expression "heart failure" doesn't imply that your heart has stopped or is going to stop working. Nonetheless, heart disappointment is a genuine condition that requires medicinal care. If you have heart failure, you may tire easily and need to restrict your exercises. Chronic Heart Disease can lead to heart failure by debilitating the heart muscle over time.
Pathophisiology
Different types of Heart complications
Clinical Diagnostic method
Case Studies and Risk Factor
Management of Diabetes induced Heart complications
Track 21: Case Studies in Diabetes and Heart:
Diabetes case studies are the detailed report of an individual, group, occasion or public. The information is gathered from a diversity of places by various methods. The contextual investigation strategy incorporates spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e. the idiographic approach. Case study permits an investigator to investigate a topic in far more detailed and minute way.
Clinical cardiology is an exceptional spotlight on thinks about including investigation and organization of heart infections, for instance, electrophysiology, cardiovascular inserts, heart recovery, cardiovascular drug, cardiovascular surgery, and recognizable proof of cardiovascular hazard factors.
Ingredients for diabetes surgery
Pertinent medical history
Methodology
Medical History
Track 22: Endocrine Complications:
The endocrine disorder is regularly very perplexing, including a blended picture of hyposecretion and hypersecretion due to the input components associated with the endocrine framework. For instance, most types of hyperthyroidism are related to an overabundance of thyroid hormone and a low level of thyroid animating hormone.
The anterior pituitary is especially sensitive to iron overloaded which upsets hormonal emission resulting in hypogonadism, short stature, acquired hypothyroidism, and hypoparathyroidism. Glucose intolerance and diabetes mellitus are additionally regular in thalassaemic patients.
Different types of Endocrine Complications
Endocrine Complications related to Diabetes
Pathophysiology
Endocrine complications and Risk Factors
Track 23: Diagnosis and Prevention: Diabetes and Heart Diseases:
Diabetes can be diagnosed based on plasma and glucose criteria or A1C criteria. Early in disease diabetes shows fewer symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnosis of diabetes includes taking blood at a health-care facility center or commercial diagnosis center and sending the sample to a lab for examination.
To assure that, the test outcomes are accurate lab investigation of the blood is required. Glucose calculating device used in a health-care provider office, such as finger-stick gadgets, is not sufficiently exact for investigation but rather might be utilized as a fast pointer of high glucose. High blood glucose can make a terrible effect on the heart. Coronary heart disease, heart disappointment can be watched habitually in the diabetes individuals.
Clinical Diabetes
Cardiovascular Disorders
Diagnosis methods of Heart Disease
Prevention methods of Diabetes and Heart Disease
Track 24: Diabetes and Dental treatment:
Microscopic organisms and inflammations in the gums may escape into the bloodstream and cause blockages in the blood vessels, which diminish blood flow to the heart. Individuals with diabetes, who have poor control of their blood glucose levels will probably develop dental health problems.
These dental issues in people will influence them by physically and financially. Intake a balanced diet, getting normal exercise and surrendering smoking propensity are advised to diminish the hazard regarding oral health problems.
Diabetes and Dental Disorders
Genetic Linkage of Diabetes and Dental disease
Gum problems
Management of Diabetes induces Gum problems
Prevention Strategy
Track 25: Cardiovascular Endocrinology:
Typical endocrine capacity is essential for cardiovascular prosperity. Disperses of the endocrine system, including hormone hyperfunction and hypofunction, adequately influence the cardiovascular framework. Likewise, we analyze the cardiovascular advantages of re-establishing ordinary endocrine capacity.
Investigation of disease transmission
Diagnostic techniques
Disease Management
Case Studies and Risk Factor
Track 26: Genetic link of Diabetes, Obesity and Heart:
Numerous genetic polymorphism has been linked to the development of type 2 diabetes. These genetic mutations can interact with the environment and the other genes to increase the risk of diabetes and its associated disorders. Different studies suggest that the type 2 diabetes is caused by both hereditary and environmental factors. Not every person who conveys a genetic mutation will get diabetes.
SNP in Diabetes, Obesity and Heart
Factors associated with Diabetes, Obesity and Heart
Case Studies of Genetic Linkage
Track 27: Diabetes and Skin problems:
Fortuitously, most skin conditions can be prevented or effectively treated if get diagnosed early. These incorporate with bacterial infections, fungal infections, and itching. Other skin problem happens mostly or only to people with diabetes.
Signs and Symptoms
Risk Factors of Diabetic and Skin Problems
Treatments
Disease associated with Diabetic and Skin Problems
Track 28: Diabetic Neuropathy and Diabetic Retinopathy:
Diabetic Neuropathy is a neuropathic issue that is related to diabetes mellitus. These conditions are thought to come about because of diabetic microvascular damage including little veins that supply nerves (vasa nervorum) in addition to macrovascular conditions that can culminate in diabetic neuropathy.
Generally, normal conditions which might be related to diabetic neuropathy incorporate third nerve paralysis; mononeuropathy; mononeuropathy multiplex; diabetic amyotrophy; an excruciating polyneuropathy; autonomic neuropathy; and thoracoabdominal neuropathy.
Diabetic retinopathy, otherwise called diabetic eye sickness, is a therapeutic condition in which damage occurs to the retina because of diabetes and is the leading cause of loss of vision.
Signs and Symptoms
Risk Factors of Diabetic Neuropathy and Diabetic Retinopathy
Track 29: Diabetic/Glycogenic Hepatopathy:
Diabetic Hepatopathy Simple steatosis or non-alcoholic steatohepatitis are liver diseases associated with diabetes mellitus (DM). To identify scientific studies and to deepen the knowledge on DH, and to evaluate the prevalence of DH in the main published studies in medical literature. Only studies that evaluated the prevalence of DH were selected, summarizing and identifying the limitations of research from 1965 to date.
Treatments
Disease associated with Diabetic Hepatopathy and Glycogenic Hepatopathy
Track 30: Diabetes Insipidus:
Diabetes insipidus is a condition characterized by large amounts of dilute urine and increased thirst. The amount of urine produced can be 20 liters per day. Central Diabetes Insipidus is due to a lack of the hormone vasopressin i.e antidiuretic hormone. Dipsogenic Diabetes Insipidus is a result of excessive fluid intake due to damage to the hypothalamic thirst mechanism. This can be due to injury to the hypothalamus or pituitary gland or genetics.
Nephrogenic Diabetes Insipidus occurs when the kidneys do not respond properly to vasopressin.. It occurs more often in those with certain psychiatric disorders or on certain medications. Gestational Diabetes Insipidus occurs only during pregnancy. Treatment involves drinking sufficient fluids to prevent dehydration. Other treatments depend on the type. In central and gestational Diabetes insipidus , treatment is with desmopressin.
Nephrogenic
Dipsogenic
Gestational
We are overwhelmed to announce 5th International Conference on "Diabetes and Endocrinology” which is going to be held during October 12-13, 2020 as a WEBINAR
DIABETES GLOBALLY: Diabetes is considered as the world’s fastest growing chronic condition. The type 2 diabetes is growing highly in each country. In 2013, diabetes caused 1.6 million deaths globally.
The World Diabetes Day is celebrated on November 14 each year. This day engages millions of diabetic patients worldwide in diabetes advocacy and awareness activities in response to growing concerns about the health threat that diabetes poses globally.
Clinical Endocrinolgy 2020 Conference invites all renowned scientists, dieticians, endocrinologists, primary health care specialists, surgeons, pharmaceutical industrial delegates, radiation therapists, general physicians, talented young scientists, and student communities across the globe to attend International Diabetes congress.
The major share in endocrine testing market share is held by companies such as Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, Biomerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics.
Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing. Furthermore, growing healthcare awareness among individuals coupled with increasing government support is expected to increase the diagnosis at an early, thereby contributing to the growth of the endocrine testing market.
The players are actively involved in launching technologically advanced products and initiate collaborative developments to sustain themselves in the competition. For instance, LabCorp offers all-embracing solutions on clinical trials pertaining to diabetes and all other hormonal diseases.
The global Next Generation Diabetes Therapy And Drug Delivery Market generated $1.25 billion in 2017 and is estimated to reach $9.67 billion by 2023, growing at a CAGR of 40.6% from 2018 to 2023. The report offers a detailed analysis of changing market trends, key investment pockets, major segments, geographical regions, and competitive scenario.
The CGM systems segment accounted for more than nine-tenths of the total revenue in 2017 and will maintain its dominance by 2023. This is due to various benefits including ease of usability and detection of levels of blood glucose. The report also explores inhalable insulin, oral insulin, and artificial pancreas.
Importance & Scope:
Clinical Endocrinology 2020 will feature the latest developments in research, diagnosis and prevention of diabetes, new insulin analogues, new technologies and devices for diabetes.
The Editors will concentrate on studies that involve wisely selected reports that provide a link between basic research and translation to diabetes-related diseases. The editors support the diffusion of distinctive solutions to challenging scientific and translational questions related with studies of Diabetes and metabolically/genetically related disorders.
Presumably, scientists in all disciplines related to Diabetes and various scientists devoted to Glucose Metabolic Homeostasis and related subjects will engage as authors of JDRT articles. Most likely those studies would be focused on indicators of disease risk and mechanisms of glucose metabolic dysregulation related diseases.
List of Diabetes Universities in Worldwide
Monash University Malaysia
International Medical University
Asia Pacific University of Technology and Innovation
Albert Einstein-Mount Sinai Diabetes Center
Columbia University
Indiana Diabetes Research Center
Joslin Diabetes Center-Harvard Medical School
Stanford Diabetes Research Center
The University of Chicago Diabetes Research
Washington University at St.Louis
Kaiser foundation Research Institute ,California San Franciso
University of Cambridge
Johns Hopkins University
Yale University
University of California, Los Angeles (UCLA)
Imperial College London
University of Melbourne
Karolinska Institute
List of Diabetes Associations Worldwide:
Diabetes Australia
Diabetes Australia Victoria
Diabetes Canada
Diabetes UK
Diabetes.co.uk
Diabetic Association of Bangladesh
European Association for the Study of Diabetes
Pacific Northwest Diabetes Research Institute
German Diabetes Center Mergentheim
Gulf Diabetes Specialist Center
Kanungo Institute of Diabetes Specialities
American Association of Clinical Endocrinologists
American Diabetes Association
Major Associations in USA:
American Diabetes Association
Centers for Disease Control: Division of Diabetes Translation
Diabetes Advocacy Alliance
Diabetes Hands Foundation
Juvenile Diabetes Foundation International
National Kidney Foundation
American Association of Clinical Endocrinologists
National Institute of Diabetes and Digestive and Kidney Diseases
International Diabetes Federation
Diabetes Association of Atlanta
List of Diabetes Societies in Worldwide:
German Diabetes Association
FAND - Italian Association of Diabetics
Italian Association for the Defence of the Interests of Diabetics
Association of Diabetes
Association National Italian Diabetic Athletes
Italian Society of Diabetology
International Diabetes Federation- Italy
Primary Care Diabetes Society
Australian Diabetes Society
Emirates Diabetes Society
Society for Biomedical Diabetes Research
Immunology of Diabetes Society
American Association of Diabetes Educators
American Diabetes Association
The Asian Association for the Study of Diabetes
International Association of the Diabetes and Pregnancy Study Groups
Diabetes Association of Nigeria
Association of Children's Diabetes Clinicians
Canadian Diabetes Association
Diabetic drugs:
The 50+ diabetes drugs available in the world in the form of tablets or injection suspension and placed into different drug’s classes.
Insulin
Biguanides / Metformin
Sulphonylureas
Meglitinides / Prandial glucose regulator / Glinides
Alpha-glucosidase inhibitors
Thiazolidinedione / Glitazones
DPP-4 inhibitors / Gliptins
Incretin mimetics / GLP-1 analogues
Amylin analogues
